person

Alban G.

Country
France
Department
Neurologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 14 partner sites.

Specializations

Neurodegenerative Disorders

The investigator’s work includes clinical studies on Alzheimer’s disease, Parkinson’s disease and related cognitive decline, aiming to evaluate disease‑modifying strategies and symptomatic therapies.

  • Alzheimer’s disease progression
  • Parkinson’s motor symptom management
  • Cognitive impairment in early dementia

These programs address unmet needs in aging populations across Europe.

Peripheral Neuropathy & Amyloidosis

Focused on hereditary transthyretin amyloidosis with polyneuropathy (ATTRv‑PN) and related cardiac involvement (ATTR‑CM), the investigator evaluates therapies that target amyloid deposition and nerve function.

  • ATTRv‑PN disease‑modifying agents
  • Cardiac amyloidosis treatment pathways
  • Peripheral nerve function preservation

This area bridges neurology and cardiology for systemic amyloid disease.

Autoimmune Neurological Disorders

Clinical trials address autoimmune conditions such as primary Sjögren’s syndrome, ANCA‑associated vasculitis and related peripheral neuropathies, exploring immunomodulatory approaches.

  • Sjögren’s‑related neuropathy therapy
  • Vasculitis‑associated nerve injury
  • Targeted biologic interventions

These studies aim to reduce inflammatory damage to the nervous system.

Neurovascular & Stroke

Research includes acute and sub‑acute management of ischemic stroke and related cerebrovascular events, focusing on reperfusion strategies and neuroprotection.

  • Acute ischemic stroke outcomes
  • Neuroprotective adjunct therapies
  • Post‑stroke functional recovery

Efforts target improvement of long‑term neurological function after vascular injury.

Neuromuscular Junction Disorders

Investigations cover disorders such as myasthenia gravis and related antibody‑mediated conditions, assessing novel immunotherapies and symptom‑control regimens.

  • Seronegative generalized myasthenia gravis
  • Antibody‑targeted treatment strategies
  • Quality‑of‑life enhancement in MG patients

The work integrates immunology and neurology to improve patient outcomes.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.